Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 9/20 | 0.77 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.51 |
| ▸ | PON1 | P27169 | 2/20 | 0.48 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | CASP1 | P29466 | 2/20 | 0.42 |
| ▸ | CASP7 | P55210 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8702627 | 0.87 | MCL1 (1.00) | MCL1AKR1B1PON1DYRK1ATDP1 | |
| SCHEMBL7462235 | 0.86 | MCL1 (0.76) | MCL1AKR1B1TDP1KDM4EALDH1A1 | |
| SCHEMBL30350025 | 0.86 | MCL1 (0.76) | MCL1AKR1B1TDP1KDM4EALDH1A1 | |
| SCHEMBL13058664 | 0.86 | HSD17B3 (0.58) | MCL1AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL17553159 | 0.86 | MCL1 (0.57) | MCL1AKR1B1TDP1KDM4EALDH1A1 | |
| SCHEMBL7459151 | 0.83 | MCL1 (0.79) | MCL1AKR1B1PON1DYRK1ATDP1 | |
| SCHEMBL31437397 | 0.82 | MCL1 (0.69) | MCL1AKR1B1TDP1KDM4EALDH1A1 | |
| SCHEMBL9277841 | 0.81 | MCL1 (0.77) | MCL1AKR1B1PON1DYRK1AKDM4E | |
| SCHEMBL14930073 | 0.81 | HSD17B3 (0.63) | MCL1AKR1B1KDM4EALDH1A1HPGD | |
| SCHEMBL299767 | 0.80 | MCL1 (0.50) | MCL1AKR1B1TDP1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250189894-A1 | PHOTOSENSITIVE SURFACE TREATING AGENT, PATTERN FORMATION SUBSTRATE, LAMINATE, TRANSISTOR, PATTERN FORMING METHOD AND METHOD OF PRODUCING TRANSISTOR | NIKON CORPORATION (JP) | 2025-06-12 | — | — | US | disclosed |
| CN-119631019-A | Photosensitive surface treatment agent, substrate for pattern formation, laminate, transistor, pattern formation method, and method for manufacturing transistor | 株式会社 尼康 | 2025-03-14 | — | — | CN | disclosed |
| WO-2024043221-A1 | PHOTOSENSITIVE SURFACE TREATMENT AGENT, PATTERN FORMATION SUBSTRATE, LAMINATE, TRANSISTOR, PATTERN FORMATION METHOD, AND TRANSISTOR MANUFACTURING METHOD | 株式会社ニコン | 2024-02-29 | — | — | WO | disclosed |
| WO-2024043221-A1 | PHOTOSENSITIVE SURFACE TREATMENT AGENT, PATTERN FORMATION SUBSTRATE, LAMINATE, TRANSISTOR, PATTERN FORMATION METHOD, AND TRANSISTOR MANUFACTURING METHOD | 株式会社ニコン | 2024-02-29 | — | — | WO | disclosed |
| US-9724417-B2 | Nanocarriers with multi-photon response elements | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-08-08 | — | — | US | disclosed |
| US-8828383-B2 | Nanocarriers with multi-photon response elements | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-09-09 | — | — | US | disclosed |
| US-8629197-B2 | Chemically patterned hydrogels, manufacture and use thereof | SHOICHET MOLLY (CA) | 2014-01-14 | — | — | US | disclosed |
| US-8629197-B2 | Chemically patterned hydrogels, manufacture and use thereof | SHOICHET MOLLY (CA) | 2014-01-14 | — | — | US | disclosed |
| US-20120259267-A1 | Chemically Amplified Response Strategies for Medical Sciences | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-10-11 | — | — | US | disclosed |
| US-7507859-B2 | Functional synthetic molecules and macromolecules for gene delivery | FIFTH BASE LLC (US) | 2009-03-24 | — | — | US | disclosed |
| US-7507859-B2 | Functional synthetic molecules and macromolecules for gene delivery | FIFTH BASE LLC (US) | 2009-03-24 | — | — | US | disclosed |
| US-20080286360-A1 | Chemically patterned hydrogels, manufacture and use thereof | SHOICHET MOLLY | 2008-11-20 | — | — | US | disclosed |
| US-20080286360-A1 | Chemically patterned hydrogels, manufacture and use thereof | SHOICHET MOLLY | 2008-11-20 | — | — | US | disclosed |
| US-6472541-B2 | HALOGENATED- COUMARIN, QUINOLINE-2-ONE, XANTHENE, THIOXANTHENE, SELENOXANTHENEN, OR ANTHRACENE DERIVATIVES; IRRADIATING TO CONTROL THE RELEASE OF THE SOMPOUND SPATIALLY AND TEMPORALLY TO PROBE ITS BIOLOGICAL EFFECTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-10-29 | — | — | US | disclosed |
| EP-1151350-A4 | PROTECTING GROUPS WITH INCREASED PHOTOSENSITIVITIES | UNIV CALIFORNIA (US) | 2002-08-21 | — | — | EP | disclosed |
| US-20020016472-A1 | PROTECTING GROUPS WITH INCREASED PHOTOSENSITIVITIES | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2002-02-07 | — | — | US | disclosed |
| EP-1151350-A1 | PROTECTING GROUPS WITH INCREASED PHOTOSENSITIVITIES | The Regents of the University of California (US) | 2001-11-07 | — | — | EP | disclosed |
| WO-2000031588-A1 | PROTECTING GROUPS WITH INCREASED PHOTOSENSITIVITIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120259267-A1 | Chemically Amplified Response Strategies for Medical Sciences | CGAS, STING1, TLR3 | MCL1 363/4885AKR1B1 4313/4885PON1 4668/4885 |
| US-20080286360-A1 | Chemically patterned hydrogels, manufacture and use thereof | CD44, CRYAA, VCL | MCL1 2839/4885AKR1B1 4828/4885PON1 2963/4885 |
| US-20020016472-A1 | PROTECTING GROUPS WITH INCREASED PHOTOSENSITIVITIES | ERCC4, XPA, GPX4 | MCL1 1400/4885AKR1B1 2111/4885PON1 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.